Author :   Tarasenko T.

Effect of chemokin polymorphisms on the efficacy of chemotherapy in patients with Her2/neu-negative breast cancer
Authors: Syvak L. Verovkina N.O. Lyalkin S. Tarasenko T.... Т. 11, № 3-4 (43-44) / Review: 19
Prognostic factors of metastatic luminal (Her2/neu-negative) breast cancer
Authors: Tarasenko T. Syvak L. Verevkina N. Lyalkin S.... T. 10, № 1-2 (37-38) / Review: 10
The role of ESR1 mutations in development of resistance to hormone therapy in patients with luminal subtypes of breast cancer
Authors: Sivak L.A. Tarasenko T. Lyalkin S. Verevkina N. Т. 8, № 1 (29) 2018 / Review: 5
Preservation of fertility in patients with breast cancer
Authors: Sivak L.A. Lyalkin S. Martynyuk O. Dosenko I.... Т. 8, № 1 (29) 2018 / Review: 1
The applying of chemotherapy in oncologic patients with functional renal lesions
Authors: Sivak L.A. Kryachok I. Ivanov D.D. Tarasenko T. №3(27) 2017 / Review: 1560
Modern approaches to the treatment of inoperable non-small cell lung cancer
Authors: Klimаnоv М.Yu. Sivak L.A. Tarasenko T. Askоlskiy А.В.... №4(24) 2016 / Review: 1
The clinical case of multiple primary cancer
Authors: Sivak L.A. Tarasenko T. Klimаnоv М.Yu. Lyalkin S.... №3(23) 2016 / Review: 2290